colon and rectal cancer

July 19, 2012

VICC adds colon cancer to gene mutation testing

Vanderbilt-Ingram Cancer Center has initiated tumor mutation testing for a limited number of patients with metastatic colorectal cancer.

By VUMC News and Communications
March 16, 2012

Colon cancer’s cellular crossroads

New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.

By VUMC News and Communications
March 10, 2012

Urine biomarker for colon cancer?

A molecule detectable in urine may be helpful in diagnosing colon cancer.

By VUMC News and Communications
January 5, 2012

Green tea totals colorectal cancer

By VUMC News and Communications
Illustration of human intestinal tract
December 1, 2011

Pathway to colon cancer progression

Molecular players involved in colon cancer progression could provide new biomarkers to indicate invasiveness and prognosis.

By VUMC News and Communications
October 7, 2011

Heart protein may be target for colon cancer therapies

A protein critical in heart development may also play a part in colon cancer progression.

By VUMC News and Communications
March 7, 2011

Enzyme protects against inflamed colon

Increasing an enzyme required for a type of colon tissue may help dampen inflammation, a known risk factor for colon cancer.
By VUMC News and Communications
1 … 5 6 7 8